Neal Padte

Biotech entrepreneur, drug developer, semi-professional trapeze artist. Operator @

[Neal Padte @NealPadte]

New publication from @RenBioNYC on ultra long-lasting GLP-1 molecules in vivo - one year of sustained weight loss from one injection. https://t.co/GhIwaXgFPk

[Neal Padte @NealPadte]

People miss how uncertain major biotech breakthroughs look in real time. As my @Curie_Bio colleague Greg Carven @MadMabScientist discusses, Keytruda came surprisingly close to never happening. Great behind-the-scenes look at drug development of a major blockbuster oncology drug.

[Alex Kesin @alexkesin]

Keytruda transformed cancer care and made Merck more money than any drug in history. It was also discovered by accident, and nearly out-licensed in 2010 for pocket change.

New Approved + exclusive interviews with the inventors and the Merck CMO who ran development:

[Neal Padte @NealPadte]

If you're a biotech founder considering applying next year, I cannot recommend it enough. Your company (and you) will be stronger because of it. (4/4) #Biotech #Entrepreneurship

https://t.co/Bqk9qbaabX

[Neal Padte @NealPadte]

Having gone through @EFrontierLabs as a founder several years ago, and now returning as a mentor, I’ve seen both sides of what makes this program work. That balance is hard to get right, and it shows the caliber of companies coming out of the program. (1/4)

[Neal Padte @NealPadte]

Grateful to be part of this incredible community of founders and entrepreneurs, especially to @ArthurKlausner for introducing me to the program in the first place! (3/4)

[Neal Padte @NealPadte]

I'm excited to share that I'm taking on a new position with our investors, https://t.co/ZbW9iov7R2. While continuing with my responsibilities at Astoria Biologica, I will also be helping Curie run more companies in their portfolio as a CXO in Residence! https://t.co/cI9QcwWAzq

[Neal Padte @NealPadte]

Thank you @LambdaLegal for fighting for equality on behalf of the LGBTQ+ community & people living with HIV for the past 50 years. Your passion and commitment was evident at the event. Thank you for your pioneering work!

[Neal Padte @NealPadte]

@DBM003 @QingMillerYang @BenjaminNilsson @virusninja Congratulations, Daniel!

[Neal Padte @NealPadte]

Full house here in Milan for the annual @ECTRIMS - ACTRIMS meeting. The Day 1 buzz is palpable. Excited to learn the latest in MS research & development. Even more excited to meet colleagues & collaborators in person after months of Zoom meetings! #MSMilan2023

[Neal Padte @NealPadte]

What a beautiful example of basic research leading to translational science leading to profound public health impact. This is just the beginning of the potential for nucleic acid-based therapeutic technologies!

[The Nobel Prize @NobelPrize]

BREAKING NEWS
The 2023 #NobelPrize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.

[Neal Padte @NealPadte]

Thanks OUTbioGNY for organizing a fantastic evening volunteering & serving ice cream to the @HetrickMartin youth. What an honor to serve this innovative organization providing essential services to LGBTQIA+ youth, sore ice-cream-scooping-arm and all!

[Neal Padte @NealPadte]

Great article on the tremendous need for non-viral nucleic acid delivery technologies like the one @RenBioNYC is creating! #NYCBiotech

https://t.co/NBeXVULDQ1

[Neal Padte @NealPadte]

Back in Boston to learn about the latest breakthroughs in neurology and to meet new colleagues in person for the first time at the American Academy of Neurology Annual Meeting. Let's go! #AANAM #AANAM2023 @AANmember

[Neal Padte @NealPadte]

Big news!

[John Carroll @JohnCendpts]

Here we go!
I have some personal business news here and it is thrilling. After lengthy transatlantic talks, The Financial Times has acquired a majority interest in Endpoints News. This is transformational for us. We’re incredibly proud to be a new part of this media enterprise

[Neal Padte @NealPadte]

Great article about one of NYC's biotech entrepreneurs. I first learned about @RocketPharma when we were neighbors at the Alexandria Center for Life Sciences and they hosted their inaugural rare disease day. It was an inspirational day. #nycbiotech

https://t.co/aY5JLPX9gS

[Neal Padte @NealPadte]

@mmaskaly Thanks Michelle!

[Neal Padte @NealPadte]

Excited to announce my new role as Founding Team Member, Head of Ops & Strategy at Astoria Biologica, a new biotech developing novel therapies for MS and backed by the new VC & therapeutics accelerator https://t.co/ZbW9iovFGA. Let's goooo!

https://t.co/hgdaj5q4X7

[Neal Padte @NealPadte]

@Novartis opening a new 15K SF office in NYC near Bryant Park. Another great example of the growing #nycbiotech ecosystem. When your team needs recs for the best breakfast BEC or lunchtime halal cart in your new neighborhood, we've got you covered!
https://t.co/mtTJD2quZF

[Neal Padte @NealPadte]

@ShafferBiotech Hi @ShafferBiotech. I spent years working on HIV antibody development programs and have folks in my network that ran NHP Ab PK studies (mainly rhesus macaques, some cynos). If this would be helpful, send me a DM with what you are looking for and I can connect you.